Announcements Trials
Browse Landscape

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 9Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Solid Tumor 3Lung Neoplasms 3Breast Neoplasms 3Glioma 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Solid Tumors 1Oncologic Diseases 1Neurotoxicity Syndromes 1Melanoma 1Liver Cirrhosis 1Glioblastoma 1Fatigue 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms, Male 1

Interventions

Sorafenib 20lenvatinib 18Hepatectomy 17Blood Specimen Collection 12Immune Checkpoint Inhibitors 11atezolizumab 9Liver Transplantation 9Surgical Procedures, Operative 7Radiofrequency Ablation 7Observation 7Bevacizumab 7regorafenib 5gadolinium ethoxybenzyl DTPA 5sintilimab 4donafenib 4camrelizumab 4Radiotherapy 4Magnetic Resonance Spectroscopy 4tislelizumab 3spartalizumab 3Polymerase Chain Reaction 3Neoadjuvant Therapy 3Mass Spectrometry 3Immunohistochemistry 3Doxorubicin 3Angiogenesis Inhibitors 3toripalimab 2pembrolizumab 2entecavir 2apatinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Carcinoma, Hepatocellular × Fluorodeoxyglucose F18 × Clear all
NCT02899325 2023-02-21

FDGal PET/CT to Detect Hepatocellular Carcinoma

British Columbia Cancer Agency

Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡